CGTX (Cognition Therapeutics Inc.) Bozor qiymatining balans qiymatiga nisbati
Cognition Therapeutics (CGTX) yangi dori vositalarini sinovdan o'tkazish xarajatlari tufayli likvidlik yetishmovchiligi va zaxiralarning kamayishi bilan yuzlashmoqda, buni 2.11 darajasidagi tegishli narxlar grafigi tasdiqlaydi. Firmaning istiqbollari sinapslarni himoya qilishda kichik molekulalarning samaradorligiga va investitsiyalarni jalb qilishga bog'liq. Kelgusidagi kapital sug'urta tizimlari orqali Altsgeymer kasalligi davolash vositalarining ommaviy savdosiga asoslanadi.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_CGTX_-_Cognition-Therapeutics_-_Capitalization-to-Book-Value-Ratio "CGTX Cognition Therapeutics, Inc. Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 29.10.2026) | 👁️GURU.Markets👁️")
Cognition Therapeutics Inc. (CGTX) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Cognition Therapeutics|CGTX - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Cognition Therapeutics|CGTX - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Cognition Therapeutics|CGTX - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzi Cognition Therapeutics
Kompaniyaning dastlabki tahlili:Cognition Therapeutics, Inc., CGTX
Cognition Therapeutics (CGTX) biotexnologiya sektori uchun, u yerda qiymat intellektual mulk va sinapslarni himoya qilish orqali yaratiladi, bozor bahosining balans qiymatidan chetlashishi demensiya terapiyasidagi kelajakdagi muvaffaqiyatlar uchun premiumni belgilaydi. Ushbu metrika bozor kapitalizatsiyasini sof aktivlar bilan bog'laydi va investorlarning molekulalarning noyob ta'sir mexanizmi uchun kompaniyaning joriy kapitaliga nisbatan qanchalik premium to'lashga tayyorligini ko'rsatadi.
Toʻgʻridan-toʻgʻri raqobatchilar
Kapitallashuvning sof aktivlarga nisbati Biogen Inc.|NBIX (neurocrine.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|Biohaven Corp (BHVN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati AMLX|Kapitallashuvning sof aktivlarga nisbati TRVI|Praxis Precision Medicines, Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Anavex (AVXL)|CBLL (CeriBell Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|Prothena - Bozor qiymatining xususiy kapitalga nisbati|Alector Therapeutics (ALEC) - Bozor qiymatining balans qiymatiga nisbati|ANNX - Kapitallashuvning balans qiymatiga nisbati|omeros.com - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Neurogene Inc|AC Immune Corp (ACIU) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori Voyager Corp|NMRA (Neumora Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi SCLX (scilexholding.com)|TVGN: Bozor qiymatining balans qiymatiga nisbati|Alpha Cognition Inc - Bozor qiymatining balans qiymatiga koeffitsiyenti|Inhibikase (IKT) - Bozor qiymatining balans qiymatiga nisbati|Cassava Pharma (SAVA) - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati assertiotx.com ASRT|Balans qiymatiga nisbatan bozor qiymati Coya Therapeutics|VistaGen Therapeutics, Inc. (VTGN) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori Ovid Rx|Acumen Pharma (ABOS) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CervoMed Corporation (CRVO)|ATHE: Bozor kapitallashuvining balans qiymatiga nisbati|Clene Inc - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati PepGen Corp (PEPG)|JUNS - Balans qiymatiga nisbatan bozor qiymati|RLMD: Bozor kapitallashuvining balans qiymatiga nisbati|ANVS (Annovis Bio Corporation) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Grace Therapeutics Inc GRCE|Sof aktivlarga nisbatan bozor kapitallashuvi fireflyneuro.com|Klotho Neurosciences Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti neurosense-tx.com NRSN|Kapitallashuvning sof aktivlarga nisbati RVPH (Reviva Pharmaceuticals Holdings)|MTVA - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati NeurAxis, Inc. NRXS|HSDT - Bozor kapitallashuvining balans qiymatiga multiplikatori|passagebio.com - Bozor kapitallashuvining balans qiymatiga nisbati|Neuphoria Therapeutics (NEUP) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati NERV|Kapitallashuvning sof aktivlarga nisbati ATHA|ADXN (Addex Therapeutics) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi alzamend.com (ALZN)|Cyclerion Therapeutics, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Protagenic Therapeutics Inc. PTIX|Bozor kapitallashuvining balans qiymatiga nisbati KTTA|Cortigent, Inc. (CRGT) - Bozor qiymatining xususiy kapitalga nisbati|ATXI - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori brainstorm-cell.com|Kapitallashuvning sof aktivlarga nisbati Cara Therapeutics (CARA)|Kapitallashuvning balans qiymatiga nisbati CHRO|Bozor qiymatining balans qiymatiga nisbati Eliem Therapeutics ELYM|Kapitallashuvning balans qiymatiga nisbati intracellulartherapies.com (ITCI)|LBPH: Bozor kapitallashuvining balans qiymatiga nisbati|MRNS - Bozor qiymatining balans qiymatiga koeffitsiyenti|NKGen Biotech - Kapitallashuvning sof aktivlarga nisbati|NRBO: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Sage Therapeutics, Inc SAGE|SNPX (Synaptogenix, Inc) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati TRVN (Trevena, Inc.)|Bozor qiymatining balans qiymatiga koeffitsiyenti Vigil Neuro|Bozor kapitallashuvining balans qiymatiga nisbati WENA (Anew Medical, Inc.)|Kapitallashuvning sof aktivlarga nisbati CERE (Cerevel Therapeutics Inc)